The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions
Year: 1986
Type: article
Source: Psychopharmacology
DOI: 10.1007/bf00179179
Institution: AstraZeneca (Sweden)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2071763279
